1 / 11

Bharti Airtel Ltd | The company reported a 14.2% sequential rise in consolidated net profit to ₹6,791 crore for Q2 FY26, surpassing CNBC-TV18’s estimate of ₹6,600 crore. Revenue climbed 5.4% QoQ to ₹52,145 crore, while EBITDA grew 6.2% to ₹29,561 crore, driven by steady growth across mobile and enterprise segments.

2 / 11

Zydus Lifesciences Ltd | The company will meet on November 6 to consider raising up to ₹5,000 crore through QIP, rights issue, preferential allotment, or private placement. The Board will also discuss seeking shareholder approval via postal ballot.

3 / 11

Gland Pharma Ltd | The company reported a 12.3% year-on-year rise in net profit to ₹184 crore for Q2 FY26, supported by steady growth in its injectables business. Revenue increased 5.8% YoY to ₹1,486

See Full Page